Copyright
©The Author(s) 2018.
World J Psychiatr. Mar 22, 2018; 8(1): 27-32
Published online Mar 22, 2018. doi: 10.5498/wjp.v8.i1.27
Published online Mar 22, 2018. doi: 10.5498/wjp.v8.i1.27
Variable | Mean | SD |
Age (yr) | 13.45 | 1.23 |
Duration of antipsychotic use (mo) | 15.67 | 1.98 |
Average number of clinical reviews | 3.43 | 0.46 |
Variable | n | % |
Age groups (yr) | ||
12-17 | 17 | 56.67 |
< 12 | 13 | 43.33 |
Gender | ||
Male | 28 | 93.33 |
Female | 2 | 6.67 |
Antipsychotic | ||
Risperidone | 23 | 76.67 |
Aripiprazole | 7 | 23.33 |
Psychiatric diagnosis | ||
ADHD | 12 | 40.00 |
ASD | 4 | 13.33 |
ADHD + ASD | 6 | 20.00 |
ADHD + other diagnosis | 6 | 20.00 |
ASD + other diagnosis | 2 | 6.67 |
- Citation: Gnanavel S, Hussain S. Audit of physical health monitoring in children and adolescents receiving antipsychotics in neurodevelopmental clinics in Northumberland. World J Psychiatr 2018; 8(1): 27-32
- URL: https://www.wjgnet.com/2220-3206/full/v8/i1/27.htm
- DOI: https://dx.doi.org/10.5498/wjp.v8.i1.27